Table 1 Baseline characteristics of the included studies
Author | Year | Number of patients (PA/EH) | Study design | Male (%) | Mean age ± SD (years) | Mean BMI ± SD (kg/m2) | Mean fasting blood glucose ± SD (mmol/L) | Ethnic | Demographic data matching | Statin use | Risj of bias by JBI |
|---|---|---|---|---|---|---|---|---|---|---|---|
Strauch [29] | 2006 | 36/28 | Cross-sectional | 50 | 50.7 ± 10.2 | 27.9 ± 4.6 | 4.9 ± 0.59 | Non-Asian | No | N/A | Moderate |
Fallo [30] | 2006 | 85/381 | Cross-sectional | 57.2 | 53.4 ± 12.4 | 27.8 ± 4.5 | 5.4 ± 1.14 | Non-Asian | No | Yes | Low |
Catena [31] | 2006 | 47/274 | Cohort | 71 | 53 ± 12 | 28.4 ± 2.9 | 4.9 ± 1 | Non-Asian | Yes | N/A | Moderate |
Ronconi [32] | 2009 | 89/164 | Cross-sectional | 52.2 | 51 ± 11 | 27.4 ± 4.3 | 5.3 ± 1.1 | Non-Asian | Yes | N/A | Low |
Matrozova [14] | 2009 | 458/1346 | Cross-sectional | 66.2 | 51.7 ± 10.4 | 27.3 ± 4.6 | 5.5 ± 0.8 | Non-Asian | Yes | N/A | Low |
Somloova [33] | 2010 | 99/90 | Cross-sectional | 54.2 | 49.9 ± 10.1 | 28.7 ± 4.6 | 5.3 ± 1.2 | Non-Asian | Yes | Yes | Low |
Fallo [34] | 2010 | 40/40 | Cross-sectional | 65 | 52 ± 9 | 26.7 ± 2.8 | 5.2 ± 0.8 | Non-Asian | Yes | Severe hyperlipidemia excluded | Low |
Stehr [35] | 2010 | 30/70 | Cross-sectional | 28 | 54.7 ± 10.8 | 30.1 ± 5.4 | 4.9 ± 0.8 | Non-Asian | Yes | N/A | Low |
Iacobellis [36] | 2012 | 75/192 | Cross-sectional | 55 | 54.9 ± 12.4 | 26.9 ± 3.6 | 5.9 ± 0.3 | Non-Asian | No | N/A | Low |
Reincke [13] | 2012 | 300/600 | Case-control | 61 | 50 ± 0 | 28 ± 03.9 | N/A | Non-Asian | Yes | N/A | Low |
Savard [37] | 2013 | 457/1273 | Cross-sectional | 65.6 | 51.2 ± 10.3 | 27.9 ± 5.0 | 5.8 ± 1.6 | Non-Asian | Yes | N/A | Low |
Prejbisz [38] | 2013 | 32/172 | Cross-sectional | 60.3 | 48.4 ± 7.7 | 30.1 ± 4.7 | N/A | Non-Asian | No | N/A | Moderate |
Liu [39] | 2014 | 50/51 | Cross-sectional | 64.3 | 41.8 ± 11.5 | 22.5 ± 3.2 | 4.8 ± 0.5 | Asian | Yes | N/A | Low |
Turchi [11] | 2014 | 102/132 | Cohort | 49.5 | 52.1 ± 10.5 | 27.2 ± 3.6 | 5.7 ± 1.4 | Non-Asian | Yes | N/A | Moderate |
Choudhary [40] | 2015 | 130/130 | Cross-sectional | 65 | 52.9 ± 16.9 | 29.9 ± 9.7 | 6.4 ± 2.7 | Non-Asian | Yes | Yes | Moderate |
Yang [41] | 2016 | 100/100 | Cross-sectional | 58 | 50 ± 12 | 25.5 ± 3.3 | 5.4 ± 1.2 | Asian | Yes | N/A | Low |
Watanabe [42] | 2016 | 32/21 | Cross-sectional | 35.8 | 56.0 ± 12.3 | 23.5 ± 4.5 | 5.3 ± 1.1 | Asian | Yes | N/A | Low |
Monticone [15] | 2017 | 99/1573 | Cross-sectional | 56.5 | 46.2 ± 8.9 | 26.1 ± 4.3 | 5.2 ± 1.1 | Non-Asian | No | N/A | Low |
Berends [12] | 2018 | 20/644 | Cross-sectional | 59.3 | 58.7 ± 11.3 | 27.8 ± 4.4 | N/A | Non-Asian | Yes | Yes | Low |
Li [43] | 2018 | 27/27 | Cross-sectional | 48.1 | 43.8 ± 11.9 | 24.1 ± 3.7 | N/A | Asian | No | N/A | Low |
Er [44] | 2019 | 100/41 | Cross-sectional | 41.8 | 50.4 ± 12.1 | 24.9 ± 3.7 | N/A | Asian | Yes | N/A | Low |
Vujacik [45] | 2020 | 40/40 | Cross-sectional | 35 | 52.8 ± 11.8 | 28.1 ± 4.5 | 5.28 ± 1.1 | Non-Asian | No | N/A | Low |
Manosroi [46] | 2020 | 41/38 | Cross-sectional | 35.4 | 38.4 ± 14.5 | 29.6 ± 6.8 | 5.42 ± 1.2 | Asian | No | N/A | Low |
Zhang [47] | 2020 | 109/109 | Cross-sectional | 40.4 | 45 ± 9.6 | 24.1 ± 3.8 | 5.42 ± 1.3 | Asian | Yes | Withdrawn 4 weeks before analysis | Low |
Hu [48] | 2020 | 49/207 | Cross-sectional | 58.6 | 49.9 ± 11.8 | 26.4 ± 3.7 | 7.7 ± 2.7 | Asian | Yes | N/A | Low |
Caprino [49] | 2020 | 32/78 | Cross-sectional | 55 | 58.1 ± 11.2 | 29 ± 4.5 | 5.3 ± 0.7 | Non-Asian | No | N/A | Low |
Sang [50] | 2021 | 36/31 | Cross-sectional | 47 | 50.8 ± 12.4 | 25.6 ± 4.0 | 5.1 ± 0.2 | Asian | No | N/A | Moderate |
Moon [10] | 2021 | 80/80 | Cross-sectional | 52.5 | 51.7 ± 12.9 | 25.3 ± 3.6 | N/A | Asian | Yes | No | Low |
Fernández-Argüeso [51] | 2021 | 50/50 | Case-control | 57 | 59.3 ± 24.5 | 30.6 ± 11.9 | 5.5 ± 3.4 | Non-Asian | Yes | Yes | Low |
Huang [52] | 2021 | 174/174 | Case-control | 48.3 | 46.2 ± 12.6 | 24.7 ± 3.9 | N/A | Asian | Yes | N/A | Low |